Sepideh Abdi
Impact in
-
- COVID-19 Clinical Research Studies
-
- COVID-19 epidemiological studies
Papers in
-
- COVID-19 Clinical Research Studies 3
-
- Sarcoma Diagnosis and Treatment 1
- Co-authors
- Kazem Zendehdel (3 shared papers)Ehsan Kazemnezhad (1 shared paper)Mahdi Sheikh (2 shared papers)Jim S. Wu (1 shared paper)Stacy E. Smith (1 shared paper)Farin Kamangar (1 shared paper)Ramesh Omranipour (1 shared paper)Gholamreza Roshandel (1 shared paper)
- Journals
- Scientific Reports (1 paper)Nicotine & Tobacco Research (1 paper)PLoS ONE (1 paper)Journal of Global Health (1 paper)Radiographics (1 paper)
- Partner nations
- IranUnited StatesUnited Kingdom
In The Last Decade
Sepideh Abdi
11 papers receiving 51 citations
Peers
Comparison fields: 5 of 35
- Infectious Diseases 12
- Modeling and Simulation 3
- Oncology 11
- Applied Psychology 2
- Health 3
Countries citing papers authored by Sepideh Abdi
This map shows the geographic impact of Sepideh Abdi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sepideh Abdi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sepideh Abdi more than expected).
Fields of papers citing papers by Sepideh Abdi
This network shows the impact of papers produced by Sepideh Abdi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sepideh Abdi. The network helps show where Sepideh Abdi may publish in the future.
Co-authors
The 25 scholars most cited alongside Sepideh Abdi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2022 | 8 | |
| 2 | 2023 | 8 | |
| 3 | 2021 | 7 | |
| 4 | 2024 | 6 | |
| 5 | 2022 | 6 | |
| 6 | Urinary Beta-2Microglobulin: An Indicator of Renal Tubular Damage after Extracorporeal Shock Wave Lithotripsy. | 2016 | 5 |
| 7 | 2021 | 3 | |
| 8 | 2022 | 3 | |
| 9 | 2023 | 3 | |
| 10 | 2024 | 2 | |
| 11 | 2023 | 1 | |
| 12 | 2025 | 0 | |
| 13 | 2026 | 0 | |
| 14 | 2026 | 0 | |
| 15 | 2025 | 0 |
About Sepideh Abdi
Sepideh Abdi is a scholar working on Infectious Diseases, Pulmonary and Respiratory Medicine, Oncology, Physiology and Molecular Biology, having authored 15 papers that have together received 52 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (3 papers), Global Cancer Incidence and Screening (2 papers), Smoking Behavior and Cessation (2 papers), Sarcoma Diagnosis and Treatment (1 paper), Musculoskeletal synovial abnormalities and treatments (1 paper), Plant and animal studies (1 paper), Hemoglobinopathies and Related Disorders (1 paper) and COVID-19 epidemiological studies (1 paper). The work is most often cited by research in Infectious Diseases (12 citations), Modeling and Simulation (3 citations), Oncology (11 citations), Applied Psychology (2 citations) and Health (3 citations). Sepideh Abdi has collaborated with scholars based in Iran, United States and United Kingdom. Frequent co-authors include Kazem Zendehdel, Ehsan Kazemnezhad, Mahdi Sheikh, Jim S. Wu, Stacy E. Smith, Farin Kamangar, Ramesh Omranipour, Gholamreza Roshandel, Mohammad Zamani and Arad Iranmehr. Their work appears in journals such as Scientific Reports, Nicotine & Tobacco Research, PLoS ONE, Journal of Global Health and Radiographics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.